Events

Past Events
2020 2019 2018 2017 2016 2015 2014 2013 2012

DSECT/DSEN Monthly Seminar Series - Jan 23 2020 - Dr. Mitch Levine

“What happens between the drug approval process and subsequent market access?”

 

Presented by

Dr. Mitchell Levine, MD MSc FRCPC FISPE FACP

Professor and Assistant Dean, Dept. Health Research Methods, Evidence & Impact and the Dept. Medicine. Div. Clinical Pharmacology and Toxicology in the Faculty of Health Sciences at McMaster University. 

Chair of the Patented Medicine Prices Review Board (PMPRB) for the government of Canada.  

Thursday, January 23, 2020 3- 4pm EST

Online via GoToWebinar

RSVP:  https://attendee.gotowebinar.com/register/2467328686373105164

 

Abstract:

The presentation will discuss the regulatory and reimbursement jurisdictions that follow once a drug has been approved for sale in Canada. The focus will be on the various steps between a Notice of Compliance (NOC) and subsequent patient access.

Learning Objectives:

  1. To understand the regulatory and reimbursement environment in Canada.
  2. To learn about changes that are occurring in the steps preceding patient access to medications.

Resources:

PMPRB http://pmprb-cepmb.gc.ca/home pCPA https://www.canadaspremiers.ca/pan-canadian-pharmaceutical-alliance/ CADTH https://www.cadth.ca/

View Attached File